European Stroke Conference, Glasgow, UK, May 29-June 1, 2007.
Quinn
T J
TJ
Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Tjq1t@clinmed.gla.ac.uk
Lees
K R
KR
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000453:epidemiology; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003952:Diagnostic Imaging; D005060:Europe; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D016896:Treatment Outcome
D000925:Anticoagulants; D005343:Fibrinolytic Agents